CareDx, Inc 1K9.F Stock
CareDx, Inc Price Chart
CareDx, Inc 1K9.F Financial and Trading Overview
CareDx, Inc stock price | 8.47 EUR |
Previous Close | 7.15 EUR |
Open | 7.5 EUR |
Bid | 7.5 EUR x 0 |
Ask | 7.6 EUR x 0 |
Day's Range | 7.5 - 7.5 EUR |
52 Week Range | 6.1 - 26.15 EUR |
Volume | 216 EUR |
Avg. Volume | 20 EUR |
Market Cap | 435.27M EUR |
Beta (5Y Monthly) | 1.008098 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -3.3 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 107.33 EUR |
1K9.F Valuation Measures
Enterprise Value | 163.32M EUR |
Trailing P/E | N/A |
Forward P/E | 19.23077 |
PEG Ratio (5 yr expected) | 14.83 |
Price/Sales (ttm) | 1.3617479 |
Price/Book (mrq) | 0.9580991 |
Enterprise Value/Revenue | 0.511 |
Enterprise Value/EBITDA | -2.33 |
Trading Information
CareDx, Inc Stock Price History
Beta (5Y Monthly) | 1.008098 |
52-Week Change | -60.21% |
S&P500 52-Week Change | 20.43% |
52 Week High | 26.15 EUR |
52 Week Low | 6.1 EUR |
50-Day Moving Average | 7.65 EUR |
200-Day Moving Average | 12.58 EUR |
1K9.F Share Statistics
Avg. Volume (3 month) | 20 EUR |
Avg. Daily Volume (10-Days) | 21 EUR |
Shares Outstanding | 53.79M |
Float | 49.72M |
Short Ratio | N/A |
% Held by Insiders | 3.97% |
% Held by Institutions | 107.77% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -25.25% |
Operating Margin (ttm) | -25.81% |
Gross Margin | 65.18% |
EBITDA Margin | -21.93% |
Management Effectiveness
Return on Assets (ttm) | -9.59% |
Return on Equity (ttm) | -18.39% |
Income Statement
Revenue (ttm) | 319.64M EUR |
Revenue Per Share (ttm) | 5.98 EUR |
Quarterly Revenue Growth (yoy) | -2.70% |
Gross Profit (ttm) | 209.58M EUR |
EBITDA | -70099000 EUR |
Net Income Avi to Common (ttm) | -80714000 EUR |
Diluted EPS (ttm) | -1.4 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 285.94M EUR |
Total Cash Per Share (mrq) | 5.32 EUR |
Total Debt (mrq) | 37.74M EUR |
Total Debt/Equity (mrq) | 8.99 EUR |
Current Ratio (mrq) | 5.171 |
Book Value Per Share (mrq) | 7.828 |
Cash Flow Statement
Operating Cash Flow (ttm) | -3100000 EUR |
Levered Free Cash Flow (ttm) | 6.45M EUR |
Profile of CareDx, Inc
Country | Germany |
State | CA |
City | South San Francisco |
Address | 8000 Marina Boulevard |
ZIP | 94005 |
Phone | 415 287 2300 |
Website | https://www.caredx.com |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | 727 |
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; and XynQAPI transplant quality tracking and waitlist management solutions, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.
Q&A For CareDx, Inc Stock
What is a current 1K9.F stock price?
CareDx, Inc 1K9.F stock price today per share is 8.47 EUR.
How to purchase CareDx, Inc stock?
You can buy 1K9.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CareDx, Inc?
The stock symbol or ticker of CareDx, Inc is 1K9.F.
Which industry does the CareDx, Inc company belong to?
The CareDx, Inc industry is Diagnostics & Research.
How many shares does CareDx, Inc have in circulation?
The max supply of CareDx, Inc shares is 51.78M.
What is CareDx, Inc Price to Earnings Ratio (PE Ratio)?
CareDx, Inc PE Ratio is now.
What was CareDx, Inc earnings per share over the trailing 12 months (TTM)?
CareDx, Inc EPS is -3.3 EUR over the trailing 12 months.
Which sector does the CareDx, Inc company belong to?
The CareDx, Inc sector is Healthcare.